Four Factors Predict Better Survival With Cabozantinib in mRCC Four Factors Predict Better Survival With Cabozantinib in mRCC

Starting cabozantinib at 60 mg/day, prior nephrectomy, favorable- or intermediate-risk disease, and BMI of 25 or higher were all significantly associated with better overall survival.Medscape Medical News
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news